Structure-based drug design methods for identifying...

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/37 (2006.01) C12N 9/00 (2006.01)

Patent

CA 2451837

The invention is based on the discovery that certain small molecules can bind to the ATP binding site of D-Ala-D-Ala ligase, even in the absence of the enzyme's substrate, and can cause a conformational change in the enzyme structure similar to that which occurs upon binding of ATP and substrate to the enzyme. Without wishing to be bound by any theory, it is believed that such a conformational change is required for either activation or inhibition of the enzyme. The information obtained from this discovery has enabled identification of key interactions in the active site of the enzyme, as well as the design and opimization of inhibitors.

Selon l'invention, on a déterminé que certaines petites molécules peuvent se lier au site de liaison d'ATP de D-Ala-D-Ala ligase, même en l'absence du substrat de l'enzyme, et peuvent provoquer dans la structure de l'enzyme une modification de la conformation similaire à celle survenant lors de la liaison d'ATP et du substrat à l'enzyme. Indépendamment de toute théorie, la présente invention énonce qu'une telle modification de la conformation est nécessaire à l'activation ou à l'inhibition de l'enzyme. Ainsi, la présente invention a permis d'identifier des interactions clé dans le site actif de l'enzyme, et de développer et d'optimiser des inhibiteurs.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Structure-based drug design methods for identifying... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Structure-based drug design methods for identifying..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Structure-based drug design methods for identifying... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1721323

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.